About the International Cardio-Oncology Society
We take cancer survival to heart.
Globally, there are nearly 50 million cancer survivors, resulting, in part, from extraordinary advancements in oncology treatments.
The International Cardio-Oncology Society is committed to raising awareness about cardiovascular disease that commonly occurs in patients undergoing treatment for cancer. The ongoing success and complexity of current life-saving therapies has led to the recognition by healthcare providers, patients, and caregivers that cardiac health is vitally important in order to obtain the best patient outcomes. We aim to enhance recognition among providers that prevention and early detection of cardiovascular disease is essential to providing optimal protection for our patients.
Cardio-Oncology promotes collaboration between oncologists, hematologists, and cardiologists to protect the cardiovascular health of all patients who are undergoing or have undergone cancer therapy.
Founded
2009
Our Vision
Eliminate cardiovascular disease as a barrier to effective cancer therapy and reduce the cardiovascular burden for those previously treated for cancer.
Our Mission
IC-OS exists to advance cardiovascular care of patients with cancer and survivors by promoting collaboration among researchers, educators, clinicians, and patients around the world.
What Is Cardio-Oncology?
Cardio-Oncology is the collaboration between oncologists, hematologists, and cardiologists to effectively and proactively protect the cardiovascular health of patients with cancer.
Hear Our Story
Learn more about the history of cardio-oncology and how we’ve helped raise awareness.Â
Our Leadership
Michael Fradley, MD
President, IC-OS
Dr. Fradley is an attending cardiologist/electrophysiologist and Medical Director, Penn Cardio-Oncology Program and Associate Professor of Clinical Medicine at the University of Pennsylvania. He is board certified in Cardiovascular Disease as well as Internal Medicine.
Dr. Fradley’s current research interests involve the treatment and prevention of cardiovascular disease in cancer patients and survivors.
Board of Directors
Alexander Lyon, MA, BM, BCh, PhD, FRCP, FHFA
Board Member
Cardio-Oncologist, Senior Lecturer
Aaron Sverdlov, MBBS PhD FRACP FCSAN FESC FHFA FACC FICOS
Board Member
Cardio-Oncologist
Anecita Fadol, PhD, APRN, FNP, FAANP, FHKAN (Hon.), FAAN
Board Member
Cardio-Oncology Nurse
